Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Vident US Bond Strategy ETF
VBND
$525M
| $9.39M | ﹤0.01% |
180,795
+139,699
| +340% | +$7.25M |
|
|
OCA.U
2602
DELISTED
Omnichannel Acquisition Corp. Units, each consisting of one share of Class A common stock and one-ha
OCA.U
| $9.38M | ﹤0.01% |
+911,200
| New | +$9.29M |
|
2603
GrowGeneration
GRWG
$104M
| $9.38M | ﹤0.01% |
233,249
+22,422
| +11% | +$604K |
|
|
SGMO
2604
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $9.38M | ﹤0.01% |
601,077
-740,273
| -55% | -$8.67M |
|
2605
Box
BOX
$4.52B
| $9.36M | ﹤0.01% |
518,645
-555,785
| -52% | -$9.68M |
|
2606
PUT
T. Rowe Price
TROW
$23.6B
| $9.36M | ﹤0.01% |
61,800
-51,600
| -46% | -$7.38M |
|
|
SIVB
2607
PUT
DELISTED
SVB Financial Group
SIVB
| $9.35M | ﹤0.01% |
24,100
-24,000
| -50% | -$7.78M |
|
2608
CALL
Crocs
CROX
$6.32B
| $9.34M | ﹤0.01% |
149,100
+62,500
| +72% | +$3.57M |
|
2609
General Dynamics
GD
$107B
| $9.34M | ﹤0.01% |
62,740
-5,089
| -8% | -$744K |
|
2610
PUT
Bunge Global
BG
$21.8B
| $9.32M | ﹤0.01% |
142,200
-43,800
| -24% | -$2.56M |
|
2611
Asana
ASAN
$2.11B
| $9.31M | ﹤0.01% |
315,202
+110,655
| +54% | +$2.83M |
|
2612
Coeur Mining
CDE
$19.3B
| $9.31M | ﹤0.01% |
899,524
+588,721
| +189% | +$4.83M |
|
2613
PUT
Old Dominion Freight Line
ODFL
$43.7B
| $9.31M | ﹤0.01% |
95,400
-111,100
| -54% | -$11.1M |
|
2614
iShares US Treasury Bond ETF
GOVT
$43.7B
| $9.3M | ﹤0.01% |
+341,519
| New | +$9.42M |
|
|
MNTV
2615
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $9.3M | ﹤0.01% |
364,011
+186,912
| +106% | +$4.21M |
|
2616
CALL
Kodiak Sciences
KOD
$2.6B
| $9.3M | ﹤0.01% |
63,300
+50,200
| +383% | +$5.6M |
|
2617
CALL
Fluor
FLR
$7B
| $9.29M | ﹤0.01% |
582,000
+255,800
| +78% | +$3.62M |
|
2618
Kinder Morgan
KMI
$73.1B
| $9.29M | ﹤0.01% |
679,941
-1,820,779
| -73% | -$24.4M |
|
2619
Core Laboratories
CLB
$571M
| $9.27M | ﹤0.01% |
349,811
-214,536
| -38% | -$4.38M |
|
2620
ResMed
RMD
$32.4B
| $9.27M | ﹤0.01% |
43,625
+23,173
| +113% | +$4.62M |
|
2621
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $9.27M | ﹤0.01% |
185,000
+62,700
| +51% | +$2.95M |
|
|
KINZU
2622
DELISTED
KINS Technology Group Inc. Unit
KINZU
| $9.27M | ﹤0.01% |
+900,606
| New | +$9.26M |
|
2623
PUT
Cboe Global Markets
CBOE
$30.9B
| $9.27M | ﹤0.01% |
99,500
-85,800
| -46% | -$7.51M |
|
2624
Manulife Financial
MFC
$73.8B
| $9.25M | ﹤0.01% |
519,221
+433,576
| +506% | +$6.92M |
|
|
2625
CALL
T. Rowe Price
TROW
$23.6B
| $9.25M | ﹤0.01% |
61,100
+8,700
| +17% | +$1.24M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.